Buy Zecyte : Abiraterone 250 Mg Tablets 120’S Online

Description

Product Overview: Zecyte is a potent medication containing 250 mg of Abiraterone per tablet, meticulously crafted by Cipla Ltd. Abiraterone, the active ingredient in Zecyte, belongs to a class of medications known as androgen biosynthesis inhibitors. It is primarily prescribed for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in adult men, either in combination with prednisone or prednisolone or with other medications as directed by a healthcare professional.

Key Features:

1. Active Ingredient: Zecyte contains Abiraterone, a selective inhibitor of CYP17 enzyme, which plays a crucial role in androgen biosynthesis. By inhibiting this enzyme, Abiraterone suppresses the production of androgens, thereby impeding the growth and progression of prostate cancer.
2. Strength: Each tablet of Zecyte comprises 250 mg of Abiraterone, ensuring a precise and standardized dosage for effective cancer treatment.
3. Packaging: Zecyte is available in a pack containing 120 tablets, providing a convenient and ample supply for continuous therapy as prescribed by healthcare providers.
4. Manufactured by Cipla Ltd.: Zecyte is manufactured with utmost precision and adherence to stringent quality standards by Cipla Ltd., a globally renowned pharmaceutical company recognized for its commitment to excellence in drug manufacturing and patient care.

Indications: Zecyte is indicated for the treatment of:

• Metastatic castration-resistant prostate cancer (mCRPC) in adult men, either in combination with prednisone or prednisolone or with other medications as directed by a healthcare professional.

Administration: Zecyte tablets are typically taken orally, once daily, on an empty stomach, at least one hour before or two hours after eating. The tablets should be swallowed whole with water and should not be crushed, chewed, or broken.

Storage: Zecyte tablets should be stored at room temperature, away from moisture and heat, in a tightly closed container. Keep Zecyte out of reach of children and pets.

Precautions:

• Prior to initiating Zecyte therapy, patients should inform their healthcare provider about any existing medical conditions, ongoing medications, or allergies.
• Regular monitoring of liver function tests, blood pressure, and electrolyte levels may be necessary during Zecyte therapy.
• Patients should avoid consuming grapefruit or grapefruit juice while taking Zecyte, as it may interact with the medication.

Adverse Reactions: Common side effects associated with Zecyte may include fatigue, joint pain, hypertension, fluid retention, hot flashes, and gastrointestinal disturbances. Patients should promptly report any severe or persistent side effects to their healthcare provider.

Disclaimer: This description provides general information about Zecyte 250 mg Tablets manufactured by Cipla Ltd. It is not intended to replace professional medical advice or serve as a comprehensive guide. Patients should consult their healthcare provider for personalized guidance regarding the use of Zecyte or any other medication.